Gentamicin Sulfate: Brands, Price & Uses in Bangladesh

Gentamicin Sulfate is an aminoglycoside antibiotic available in Bangladesh as an injectable formulation (for systemic infections) and as topical/ophthalmic preparations (eye drops, eye ointment, and ear drops). Its uses differ significantly by formulation and route.

Injectable (Systemic) Use - FDA-Approved / Established

• Serious infections caused by susceptible strains of gram-negative bacteria, including Pseudomonas aeruginosa, Escherichia coli, Klebsiella, Enterobacter, Serratia, Citrobacter, and indole-positive and indole-negative Proteus species
• Septicemia (bloodstream infection)
• Complicated and serious urinary tract infections
• Bacterial meningitis (often as part of combination therapy)
• Serious lower respiratory tract infections
• Intra-abdominal infections, including peritonitis
• Serious skin, bone, and soft-tissue infections, and infected burns

Combination therapy: Gentamicin Sulfate is frequently used together with a beta-lactam antibiotic (e.g., penicillin or ampicillin) for synergistic coverage against certain gram-positive organisms, such as in Staphylococcus aureus infections and streptococcal/enterococcal endocarditis. It should not be physically mixed in the same syringe or IV bag with beta-lactam antibiotics (see Drug Interactions).

Neonatal sepsis: Gentamicin Sulfate is a guideline-supported component of empiric combination therapy for suspected early-onset neonatal sepsis.

Topical/Ophthalmic Use - Established

• Superficial bacterial infections of the eye caused by susceptible organisms, including conjunctivitis, blepharitis, blepharoconjunctivitis, keratitis, and corneal ulcers
• Bacterial infections of the outer ear (otitis externa)
• Susceptible superficial skin infections (topical cream/ointment forms)

Formulation choice should be guided by a physician based on the site and severity of infection; ophthalmic/topical forms are not effective for, and must never be substituted for, systemic infections.

Dosing of Gentamicin Sulfate must always be individualized by a physician based on the indication, body weight, renal function, and (for systemic use) serum drug-level monitoring. Take exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice. The information below is general guidance and does not replace medical advice.

For systemic (injectable) therapy, duration is typically 7-10 days, guided by clinical response; longer courses increase the risk of nephrotoxicity and ototoxicity and require close monitoring (see Precautions and Warnings). Peak and trough serum concentration monitoring is recommended for systemic therapy, particularly beyond 3 days, in renal impairment, or in neonates and the elderly.

Side effects of Gentamicin Sulfate depend substantially on the route of administration.

Systemic (Injectable) Use

• Nephrotoxicity: kidney damage, which is usually reversible if detected early and the drug is discontinued or the dose adjusted; risk increases with higher doses, longer duration, dehydration, pre-existing renal impairment, and concurrent nephrotoxic drugs.
• Ototoxicity: damage to hearing (cochlear toxicity - tinnitus, hearing loss) and/or balance (vestibular toxicity - dizziness, vertigo, unsteadiness); this can be irreversible and may not appear until after treatment has ended.
• Neuromuscular blockade: muscle weakness or, rarely, respiratory paralysis, especially with rapid infusion, high doses, or in patients with neuromuscular disorders.
• Other reported effects: nausea, vomiting, rash, fever, headache, injection-site pain, and laboratory abnormalities (elevated liver enzymes, low magnesium/potassium/calcium).

Ophthalmic/Topical Use

• Local burning, stinging, or itching upon instillation
• Conjunctival redness (hyperemia) or irritation
• Rarely, allergic/hypersensitivity skin reactions or delayed corneal healing with prolonged use